de Vera ME - Search Results

1

Pharmacologic administration of interleukin-2.

Chavez AR, Buchser W, Basse PH, Liang X, Appleman LJ, Maranchie JK, Zeh H, de Vera ME, Lotze MT. Chavez AR, et al. Among authors: de vera me. Ann N Y Acad Sci. 2009 Dec;1182:14-27. doi: 10.1111/j.1749-6632.2009.05160.x. Ann N Y Acad Sci. 2009. PMID: 20074271

2

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

Liang X, De Vera ME, Buchser WJ, Romo de Vivar Chavez A, Loughran P, Beer Stolz D, Basse P, Wang T, Van Houten B, Zeh HJ 3rd, Lotze MT. Liang X, et al. Among authors: de vera me. Cancer Res. 2012 Jun 1;72(11):2791-801. doi: 10.1158/0008-5472.CAN-12-0320. Epub 2012 Apr 3. Cancer Res. 2012. PMID: 22472122 Free PMC article.

3

The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Romo de Vivar Chavez A, de Vera ME, Liang X, Lotze MT. Romo de Vivar Chavez A, et al. Among authors: de vera me. Med Oncol. 2009;26 Suppl 1:3-12. doi: 10.1007/s12032-008-9162-z. Epub 2009 Jan 16. Med Oncol. 2009. PMID: 19148593 Review.

4

Masquerader: high mobility group box-1 and cancer.

Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT. Ellerman JE, et al. Clin Cancer Res. 2007 May 15;13(10):2836-48. doi: 10.1158/1078-0432.CCR-06-1953. Clin Cancer Res. 2007. PMID: 17504981 Review.

5

Ethyl pyruvate administration inhibits hepatic tumor growth.

Liang X, Chavez AR, Schapiro NE, Loughran P, Thorne SH, Amoscato AA, Zeh HJ, Beer-Stolz D, Lotze MT, de Vera ME. Liang X, et al. Among authors: de vera me. J Leukoc Biol. 2009 Sep;86(3):599-607. doi: 10.1189/jlb.0908578. J Leukoc Biol. 2009. PMID: 19584311

6

The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity.

Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tör M, Billiar T. Lotze MT, et al. Immunol Rev. 2007 Dec;220:60-81. doi: 10.1111/j.1600-065X.2007.00579.x. Immunol Rev. 2007. PMID: 17979840 Review.

7

Simultaneous pancreatectomy and liver transplantation: a single-institution experience.

Dhupar R, de Vera ME, Marsh JW, Fontes PA, Steel JL, Zeh HJ, Gamblin TC. Dhupar R, et al. Among authors: de vera me. HPB (Oxford). 2009 May;11(3):242-6. doi: 10.1111/j.1477-2574.2009.00043.x. HPB (Oxford). 2009. PMID: 19590654 Free PMC article.

8

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter.

de Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM Jr, Billiar TR, Geller DA. de Vera ME, et al. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1054-9. doi: 10.1073/pnas.93.3.1054. Proc Natl Acad Sci U S A. 1996. PMID: 8577713 Free PMC article.

9

Getting a handle on posttransplant recurrence of HCC.

de Vera ME. de Vera ME. Oncology (Williston Park). 2009 Dec;23(14):1287, 1291. Oncology (Williston Park). 2009. PMID: 20120842 Free article. No abstract available.

10

Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease.

Sakai T, Planinsic RM, Mathier MA, de Vera ME, Venkataramanan R. Sakai T, et al. Among authors: de vera me. Transpl Int. 2009 May;22(5):554-61. doi: 10.1111/j.1432-2277.2008.00830.x. Epub 2008 Jan 19. Transpl Int. 2009. PMID: 19175541 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters